Skip to content
MegAligna

Comparison

CentralReach pricing: what a quote actually depends on

CentralReach does not publish a rate card, so every price is a quote. What moves that quote is your active clinician headcount, which modules you take, and what implementation involves, rather than a per-client rate you can look up. Any figure circulating online is a third-party estimate.

There is no published number, and that is the answer

CentralReach sells by quote. There is no rate card to look up, no per-seat price on a public page, and no self-serve checkout — which means that every figure you find in a forum thread, a review-site comparison or a “CentralReach pricing 2026” listicle is one customer’s recollection of one quote, at one headcount, with one module mix, at one point in time.

Those numbers are not useless, but they are not prices. Treating them as prices is how agencies end up anchored to a figure that turns out to describe an organization half their size.

What actually moves the quote

Quote-based enterprise software prices on a handful of variables, and these are the ones worth knowing before you take the call, because each is something you can size in advance:

Active clinician headcount. The primary driver almost everywhere in this category. Know your real number of people who will log in weekly, not your total staff list — the gap between those two is often twenty per cent and it is always in the vendor’s favour to use the larger one.

Module mix. Broad platforms are modular, and the difference between a records-and-scheduling configuration and a full revenue-cycle configuration is not marginal. Decide which modules you would actually use before the demo, or you will be quoted for the demo you were shown.

Implementation and data migration. Ask whether it is a separate line, what it covers, and what happens if it overruns. This is frequently the largest first-year cost after licences and the one least visible in a comparison.

Contract length and escalators. A multi-year term usually buys a lower headline rate. Ask what the renewal looks like and whether there is a cap on the annual increase, because a rate that resets at renewal is a different product from one that does not.

Client or learner volume. Some platforms in this market price partly on clients served, some do not. Ask explicitly, because if your caseload grows faster than your headcount, a client-linked component changes your three-year number substantially.

The questions to ask before you accept a quote

  1. What is the total at our headcount and caseload, all modules included, for year one and year three?
  2. Which line items are one-time and which recur?
  3. What is the annual increase at renewal, and is it capped?
  4. What happens to the price if we shrink? Growth is always priced; contraction rarely is.
  5. What does a full export of our own data look like on the day we leave, and is it a chargeable professional-services engagement?

Question five is the one people skip and the one that decides how expensive leaving is. Ask it of every quote-only vendor, including the one you stay with.

Reading a quote against a published price

The practical difficulty with an all-quote shortlist is that there is no reference point — every number arrives already shaped by what the vendor learned about you on the discovery call.

Putting at least one published-price vendor on the shortlist fixes that, because it gives you an arithmetic baseline the quotes can be read against. Among ABA platforms, Motivity and Raven Health publish per-learner rates, and MegAligna publishes its own: per active clinical seat, with clients never charged for, which means the number you compute is the number you pay.

That difference in pricing unit matters more than the rate. A per-seat product and a per-client product diverge as soon as your caseload-to-clinician ratio changes, and they diverge in opposite directions depending on which way it moves.

Where MegAligna fits, and where it does not

If you are pricing CentralReach, you are evaluating a mature platform, and the honest statement is that a newer product is a different kind of bet rather than a cheaper version of the same one. See the full comparison for where that lands.

What is genuinely missing here: claims are not transmitted to payers. Finished charges and CMS-1500 field data go to your biller. An agency that submits electronically today would be giving that up, and no price difference compensates for that if it is how you operate.

Common questions

How much does CentralReach cost?
There is no published price. CentralReach sells by quote, so the cost depends on your active clinician headcount, which modules you take, implementation scope and contract length. Any specific figure you find online is one customer's recollection of one quote rather than a rate card.
Does CentralReach charge per user or per client?
That is exactly the question to put to them directly, because the pricing unit matters more than the rate. A per-seat product and a per-client product diverge as soon as your caseload-to-clinician ratio changes, and in opposite directions depending on which way it moves.
Is there a free trial?
Quote-based platforms in this category generally run a scoped evaluation or pilot rather than an open trial. If you can get one, run a single team in parallel with your current system for a period — a demo shows you the product working, a parallel run shows you your practice working. A pilot on real client records needs that vendor's business associate agreement signed first, so ask for it before the pilot is scheduled rather than after.
Which ABA platforms do publish pricing?
Motivity and Raven Health publish per-learner rates, and MegAligna publishes a per-active-clinical-seat price with clients free. Including at least one published-price vendor on a shortlist gives the quotes you receive a reference point they otherwise lack.

See a price without asking for one

14 days, no card required. Use made-up patients while you evaluate — real patient information waits until a business associate agreement is in place.